Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells to Cardiomyocytes A Methods Overview
Top Cited Papers
- 19 July 2012
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 111 (3), 344-358
- https://doi.org/10.1161/CIRCRESAHA.110.227512
Abstract
Since human embryonic stem cells were first differentiated to beating cardiomyocytes a decade ago, interest in their potential applications has increased exponentially. This has been further enhanced over recent years by the discovery of methods to induce pluripotency in somatic cells, including those derived from patients with hereditary cardiac diseases. Human pluripotent stem cells have been among the most challenging cell types to grow stably in culture, but advances in reagent development now mean that most laboratories can expand both embryonic and induced pluripotent stem cells robustly using commercially available products. However, differentiation protocols have lagged behind and in many cases only produce the cell types required with low efficiency. Cardiomyocyte differentiation techniques were also initially inefficient and not readily transferable across cell lines, but there are now a number of more robust protocols available. Here, we review the basic biology underlying the differentiation of pluripotent cells to cardiac lineages and describe current state-of-the-art protocols, as well as ongoing refinements. This should provide a useful entry for laboratories new to this area to start their research. Ultimately, efficient and reliable differentiation methodologies are essential to generate desired cardiac lineages to realize the full promise of human pluripotent stem cells for biomedical research, drug development, and clinical applications. (Circ Res. 2012;111:344-358.)Keywords
This publication has 129 references indexed in Scilit:
- Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cellsJournal of Molecular and Cellular Cardiology, 2011
- Directed Differentiation of Human Embryonic Stem Cells to Interrogate the Cardiac Gene Regulatory NetworkMolecular Therapy, 2011
- Opportunities for Use of Human iPS Cells in Predictive ToxicologyClinical Pharmacology & Therapeutics, 2011
- Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell LinesCell, 2011
- Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndromeNature, 2010
- The extracellular matrix in development and morphogenesis: A dynamic viewDevelopmental Biology, 2010
- The microwell control of embryoid body size in order to regulate cardiac differentiation of human embryonic stem cellsBiomaterials, 2010
- Development of scalable culture systems for human embryonic stem cellsBiochemical Engineering Journal, 2010
- Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in miceDevelopmental Biology, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007